1,720,994 research outputs found
CA 19-9 as a prognostic index after resection for pancreatic cancer.
Serial serum CA 19-9 assays were performed in 30 consecutive patients who underwent resection for pancreatic cancer. Patients with preoperative CA 19-9 levels 200 U/ml (P < 0.001). Serum tumor marker normalized in 14 patients after tumor resection, and survival in this group was significantly higher than that of patients with persistently elevated CA 19-9 (P < 0.0001). Prognosis was also influenced by absence of lymph node metastases (P < 0.02) and radicality of resection (P < 0.005). Elevation of serum CA 19-9 levels after operation well predicted tumor recurrence from 1-10 months before clinical and radiological evidence. CA 19-9 determination is useful as a prognostic index after resection for pancreatic carcinoma and as a surveillance test in monitoring the efficacy of treatment
Recommended from our members
Aminoguanidine inhibits the generation of nitric oxide in vitro and prolongs islet xenograft survival in rats.
Effect of orchiectomy and testosterone replacement on experimental pancreatic carcinogenesis.
Gamma irradiation and aminoguanidine administration prolongs pig to rat islet cells xenograft survival
The prognostic significance of serum CA 19-9 in patients with pancreatic adenocarcinoma.
- …
